INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43m ago
HOUSE PTR3m ago
SEC 13F3m ago
ROBINHOOD CHAIN3m ago
Corporate insider
PN

Parker Charles Nolan

Chief Financial OfficerCIK 0002125562

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score24
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
15.4K sh
Dec 12, 2025Apr 8, 2026
traded Dec 12, 2025
+117dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Traws Pharma, Inc.Chief Financial Officer · Apr 8, 2026
24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A
—
32.4K sh
Oct 12, 2025
Apr 8, 2026
traded Oct 12, 2025
+178d
SEC FORM 4

Evidence

24
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
61.6K sh
Dec 12, 2025Apr 8, 2026
traded Dec 12, 2025
+117dSEC FORM 4

Evidence

19
PN
Parker Charles NolanChief Financial Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
104.5K sh
Mar 8, 2026Apr 8, 2026
traded Mar 8, 2026
+31dSEC FORM 4

Evidence